Cited by 1,193Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 280 of the 286 references it cites were found in a registry or an index.

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Open access

Arnett, Donna K., Blumenthal, Roger S., Albert, Michelle A., Buroker, Andrew B., Goldberger, Zachary D., Hahn, Ellen J., Himmelfarb, Cheryl Dennison, Khera, Amit, Lloyd-Jones, Donald, McEvoy, J. William, Michos, Erin D., Miedema, Michael D., Muñoz, Daniel, Smith, Sidney C., Virani, Salim S., Williams, Kim A., Yeboah, Joseph, Ziaeian, Boback·2019·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2019.03.009PMC PMC8344373

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.03.009

Cites

280 of 280 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation

Show all 286 references

Research works printed but not linked: 13

DeFilippis, 2017, Eur Heart J, 38, 598
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 · DOI
Nasir, 2015, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 · DOI
Yano, 2017, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies, JAMA Cardiol, 2, 986, 10.1001/jamacardio.2017.2498 · DOI
Budoff, 2018, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA), Eur Heart J, 39, 2401, 10.1093/eurheartj/ehy217 · DOI · Paper page
Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 · DOI · Paper page
Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI
Patnode, 2015, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force, Ann Intern Med, 163, 608, 10.7326/M15-0171 · DOI · Paper page
Guirguis-Blake, 2016, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 804, 10.7326/M15-2113 · DOI

Sorted by citations

Items 601–700 of 1,000

Dyslipidemia: Current Therapies and Strategies to Overcome Barriers for Use
DePhillips, C., Parikh, P. B., & Stevens, G. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.08.012 · Cited by 7
Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015–2019 in South Korea
Lee, Y. J., Shin, J. H., Kim, Y., & Kim, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259467 · Cited by 7
Cardiovascular Outcomes in Systemic Lupus Erythematosus
Sairam, S., Sureen, A., Gutierrez, J., Dang, T. Q., & Mishra, K. (2022) · Current Cardiology Reports · doi:10.1007/s11886-021-01626-9 · Cited by 7
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer
Alvi, R. M., Quinaglia, T., Spahillari, A., Abreu, G. A. S., Hassan, M. Z. O., Gongora, C. A., Gilman, H. K., Nikolaidou, S., Sama, S., Wirth, L. J., et al. (2022) · Cancers · doi:10.3390/cancers14153651 · Cited by 7
Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China
Zheng, R., Xu, Y., Li, M., Lu, J., Wu, S., Niu, J., Zhao, Z., Chen, L., Huo, Y., Xu, M., et al. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.008774 · Cited by 8
Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding
Li, D. K., Ong, S. Y., Hughes, M. L., Hung, K. W., Agarwal, R., Alexis, J. O., Damianos, J., Sharma, S., Pires, J., Nanna, M. G., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17278 · Cited by 7
Lipid accumulation product is closely associated with hypertension and prehypertension in prediabetic population in China: results from the REACTION study
Li, B.-Q., Wang, J., Zhou, X., Wang, W.-Q., Gao, Z.-N., Tang, X.-L., Yan, L., Wan, Q., Luo, Z.-J., Qin, G., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01113-w · Cited by 7
Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry
Lorca, R., Aparicio, A., Salgado, M. C. D. O., Álvarez‐Velasco, R., Pascual, I., Gómez, J., Vázquez‐Coto, D., García-Lago, C., Velázquez-Cuervo, L., Cuesta‐Llavona, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144812 · Cited by 7
“Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide [1,2], coronary artery disease (CAD) being a major concern.”
Background
Coronary artery calcium score: we know where we are but not where we may be
Mattesi, G., Savo, M. T., Amicis, M. D., Amato, F., Cozza, E., Corradin, S., Pozzo, S. D., Previtero, M., Bariani, R., Conti, G. D., et al. (2023) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2023.2720 · Cited by 8
Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making
Sarkar, S., Orimoloye, O. A., NASS, C. M., Blumenthal, R. S., & Martin, S. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05266-2 · Cited by 7
Self-citation
Coronary artery calcium scoring in individuals at risk for coronary artery disease: current status and future perspectives
Vonder, M., van der Aalst, C. M., & de Koning, H. J. (2020) · British Journal of Radiology · doi:10.1259/bjr.20190880 · Cited by 8
Independence of coronary artery disease to subclinical left ventricular dysfunction
Venkataraman, P., Wright, L. M., Huynh, Q. L., & Marwick, T. H. (2020) · Echocardiography · doi:10.1111/echo.14657 · Cited by 7
Recent dyslipidemia guidelines for patients with diabetes mellitus
Rhee, E. (2020) · Precision and Future Medicine · doi:10.23838/pfm.2020.00100 · Cited by 7
Coronary artery disease and non‐alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans
Kirby, R. S., & Halegoua-DeMarzio, D. L. (2021) · JGH Open · doi:10.1002/jgh3.12509 · Cited by 7
The role of cardiovascular CT in occupational health assessment for coronary heart disease: An expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT)
Slim, A. M., Fentanes, E., Cheezum, M. K., Parsons, I., Maroules, C. D., Chen, B., Abbara, S., Branch, K. R., Nagpal, P., Shah, N. R., et al. (2021) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2021.03.010 · Cited by 7
“atherosclerotic cardiovascular disease (ASCVD) score (63) to initiate aggressive risk factor management or additional cardiac testing However, additional cardiac stress testing is more controversial and other testing, such as CACS, has not been reported in this population.”
Background
Effect of Periodontal Disease on Long-Term Outcomes After Percutaneous Coronary Intervention for De Novo Coronary Lesions in Non-Smokers
Fukushima, T., Yonetsu, T., Aoyama, N., Tashiro, A., Niida, T., Shiheido‐Watanabe, Y., Maejima, Y., Isobe, M., Iwata, T., & Sasano, T. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0720 · Cited by 7
High- vs. Low-Intensity Statin Therapy and Changes in Coronary Artery Calcification Density after One Year
Vogel, L. H., Dykun, I., Raggi, P., Schmermund, A., Rassaf, T., & Mahabadi, A. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020476 · Cited by 7
Performance of polygenic risk scores in screening, prediction, and risk stratificationPreprint
Hingorani, A. D., Gratton, J., Finan, C., Schmidt, A. F., Patel, R. S., Sofat, R., Kuan, V., Langenberg, C., Hemingway, H., Morris, J. K., et al. (2022) · medRxiv · doi:10.1101/2022.02.18.22271049 · Cited by 7
Can we measurably improve the prediction of recurrent coronary artery disease events?
Weintraub, W. S., & Boden, W. E. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad464 · Cited by 7
Causal effects of the residential environment on hypertension, heart disease, and asthma: A cross-lagged panel model from a prospective cohort study
Arata, S., Kamata, T., Murakami, S., Ikaga, T., & Kawakubo, S. (2024) · Building and Environment · doi:10.1016/j.buildenv.2024.112516 · Cited by 6
Association between dental floss use and atherosclerotic cardiovascular disease in American adults
Fei, J., & Gong, X. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.02.003 · Cited by 6
Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study
Martinez, K. A., Montori, V. M., Rodríguez, F., Tereshchenko, L. G., Kovach, J. D., Boyer, C., Hurwitz, H., & Rothberg, M. B. (2025) · Medical Decision Making · doi:10.1177/0272989x251346508 · Cited by 6
AI assisted focused cardiac ultrasound in preventive cardiology – a perspective
Cohen, I., Lakritz, A., & Maor, E. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00063-9 · Cited by 7
“Guidelines seek to address this by categorizing patients into distinct risk groups and utilizing risk calculators that consider factors such as age, sex, smoking status, blood pressure, andcholesterol levels 6,7 .”
Role of impaired mitochondrial dynamics and mitophagy in cardiovascular diseases: Possible therapeutic approaches
Sarkar, S., Chattopadhyay, A., & Bandyopadhyay, D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123890 · Cited by 7
Polygenic Risk Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials
Abou-Karam, R., Seo, M. S., Cho, S. M. J., Bitar, F., Gady, S., Cheng, F., Thrompson, A. G., Karlson, E. W., Natarajan, P., Ellinor, P. T., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.12.032 · Cited by 7
Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond
Shah, L. M., Wand, A., Ying, W., Hays, A. G., Blumenthal, R. S., Barouch, L. A., Zakaria, S., & Sharma, G. V. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.696 · Cited by 6
Self-citation
The Role of Cancer in the Risk of Cardiovascular and All-Cause Mortality: A Nationwide Prospective Cohort Study
Shen, R., Wang, J., Wang, R., Tian, Y., Guo, P., Shen, S., Liu, D., & Zou, T. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1606088 · Cited by 6
First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults
Bagherikholenjani, F., Shahidi, S., Vaseghi, G., Ashoorion, V., Sarrafzadegan, N., Siavash, M., Heidarpour, M., Shahidi, S., Sadeghi, M., Mohammadifard, N., et al. (2024) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_318_23 · Cited by 8
“[14]”
Association between movement behavior patterns and cardiovascular risk among Chinese adults aged 40–75: a sex-specific latent class analysis
Chen, Y., Song, Y., Zhou, N., Wang, W., & Hong, X. (2024) · BMC Public Health · doi:10.1186/s12889-024-18573-z · Cited by 6
“Furthermore, our approach integrates data and consensus to better elucidate the heterogeneity within a large sample of individuals of a specific age group, who are recommended to undergo routine assessments for traditional CVD risk factors [9].”
BackgroundMethodResultInfluential
Assessment of Long-Term Engagement in Aerobic Versus Resistance Exercise on 20-Year Cardiovascular Disease Incidence (2002–2024): The ATTICA Epidemiological Cohort Study
Dimitriadis, N., Arnaoutis, G., Chrysohoou, C. A., Barkas, F., Liberopoulos, E. N., Sfikakis, P. P., Pitsavos, C. S., Tsioufis, C. P., Tambalis, K. D., & Panagiotakos, D. B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020522 · Cited by 7
Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium
Wang, F. M., Ballew, S. H., Folsom, A. R., Wagenknecht, L. E., Howard, C. M., Coresh, J., Budoff, M. J., Blaha, M. J., & Matsushita, K. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.01.019 · Cited by 6
A Rare Case of Statin-Induced Necrotizing Autoimmune Myopathy
Shuster, S., & Awad, S. (2020) · AACE Clinical Case Reports · doi:10.4158/accr-2019-0547 · Cited by 6
The cardiometabolic benefits of exercise in postmenopausal women
Chrysant, S. G. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13968 · Cited by 6
Association of vitamins, minerals, and lead with lipoprotein(a) in a cross-sectional cohort of US adults
Brandt, E. J., Brandt, D. J., Desai, N. R., Spatz, E. S., Nasir, K., & Mani, A. (2021) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000709 · Cited by 6
On the prevention and treatment of Alzheimer’s disease: Control the promoters and look beyond the brain
Goldstein, M. R., & Cheslock, M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110645 · Cited by 8
Statin Use in Hospitalized Patients with COVID-19: A Comprehensive Analysis of the New York City Public Hospital System
Li, W., Rios, S. A., Nagraj, S., Hajra, A., Saralidze, T., Varrias, D., Mathai, S. V., Novakovic, M., Hupart, K. H., Miles, J. A., et al. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.02.018 · Cited by 6
C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome
Zamani, B., Golabchi, A., Ghadakkar, N., & Motedayyen, H. (2022) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2022.2119866 · Cited by 7
Reducing the Threshold of Primary Prevention of Cardiovascular Disease to 10% Over 10 Years: The Implications of Altered Intensity “Statin” Therapy Guidance
Sultan, S., Khan, S. U., Holden, K., Hendi, A. A., Saeed, S., Abbas, A. H., Zaman, U., Naeem, S., & Rehman, K. U. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101486 · Cited by 6
Helicobacter pylori-Positive Gastric Biopsies—Association with Clinical Predictors
Negovan, A. E., Cozac-Szőke, A. R., Mocan, S. L., & Bănescu, C. V. (2022) · Life · doi:10.3390/life12111789 · Cited by 6
Adherencia al tratamiento y nivel de conocimiento en adultos con hipertensión arterial, Asunción 2022
Mello, L. C. R., Batista, V. A., Morínigo, P. E. B., Florentín, C. D. B., Alvarenga, M. J. C., Cabrera, N. M. J., Ocampos, A. R. M., Rolón, N. G. M., Aguilar, G. M. R., Rotela, P. S. S., et al. (2023) · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · doi:10.18004/rvspmi/2312-3893/2023.10.01.11 · Cited by 6
Five-Year Changes in Inflammatory, Metabolic, and Oxidative Biomarkers and 10-Year Cardiovascular Disease Incidence: The REGICOR Cohort Study
Camps-Vilaro, A., Subirana, I., Ramos, R., Cainzos‐Achirica, M., Tizón‐Marcos, H., Fitó, M., Degano, I. R., & Marrugat, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097934 · Cited by 6
Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review
Desjardins, C., Cyrenne-Dussault, M., Barbier, O., Bélanger, A., Gangloff, A., Guénette, L., Leclerc, J., Lefèbvre, J., Zongo, A., & Drouin‐Chartier, J. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.010 · Cited by 6
The Scope of Practice for Primary Cardiovascular Disease Prevention Expanded to Advanced Practice Providers: What Does the Data Show?
Iqbal, S., Ali, N., Ladak, L., Shivji, R., Zulfiqar, M., & Barolia, R. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01899-2 · Cited by 6
Cardiovascular disease prevention in women – the current state in 2023
Purohit, A. M., Kim, Y. J., & Michos, E. D. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001099 · Cited by 6
Self-citation
PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): a prospective longitudinal study protocol investigating the prevalence, severity and determinants of atherosclerotic cardiovascular disease in the young adult Pakistani population
Hanif, B., Sheikh, S., Peerwani, G., Caínzos-Achirica, M., Javed, W., Baqar, J. B., Samad, Z., Bashir, F., Virani, S. S., Nasir, K., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076045 · Cited by 7
Self-citation
The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations
Mulvagh, S. L., Colella, T. J. F., Gulati, M., Crosier, R., Allana, S., Randhawa, V. K., Bruneau, J., Pacheco, C., Jaffer, S., Cotie, L. M., et al. (2023) · CJC Open · doi:10.1016/j.cjco.2023.12.001 · Cited by 10
“59 Beyond guidelines for the prevention of CVD, there are other guidelines that mention women within sections labelled “ special populations, ” including the recent AHA/ACC HF guideline, which mentioned the increased risk of HFpEF in women, pointing out the sex differences in speci ﬁ c biomarkers…”
Background
Pharmacotherapeutic options for the treatment of hypertension in pregnancy
Conti-Ramsden, F. I., de Marvao, A., & Chappell, L. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2398602 · Cited by 11
Nutritional Therapy for Asian Patients at Risk for Atherosclerotic Cardiovascular Disease
Lim, H., Kim, J., & Kim, D.-Y. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.192 · Cited by 7
Association between real‐world home blood pressure measurement patterns and blood pressure variability among older individuals with hypertension: A community‐based blood pressure variability study
Lin, J., Kuo, K., Kuo, Y., Wu, K., Chu, K., Jiang, Y., Chuang, Y., & Cheng, H. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14134 · Cited by 6
Coronary artery calcium scoring at lower tube voltages – Dose determination and scoring mechanism
Zhang, D., Scott, A. W., Lee, C., Gellada, N. H., Hyun, M. C., & Zhou, Y. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109680 · Cited by 6
A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users
Mallah, N., Zapata‐Cachafeiro, M., Aguirre, C., Ibarra-García, E., Palacios–Zabalza, I., García, F. M., Iglesias‐García, J., Piñeiro‐Lamas, M., Ibáñez, L., Vidal, X., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99402-w · Cited by 6
Contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes in Brazil: the cross-sectional CAPTURE study
Vencio, S. A. C., Vianna, A. G. D., da Silva, M. A. C. F., & Précoma, D. B. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00775-9 · Cited by 6
A New Marker for Determining Cardiovascular Risk: Salusin Alpha
Yılmaz, E., Kurt, D., Aydın, E., Çamcı, S., & Vural, A. (2022) · Cureus · doi:10.7759/cureus.30340 · Cited by 6
Cardiovascular and renal protection with sodium-glucose cotransporter type 2 inhibitors: new paradigm in type 2 diabetes management…and potentially beyond
Scheen, A. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.05.82 · Cited by 6
Pre-eclampsia and future cardiovascular diseases: How to assess the risk?
Santulli, G., & Al-Mallah, M. H. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.004 · Cited by 6
Sex Differences in Coronary Plaque Composition and Progression
Nasir, K., Sharma, G. V., & Blumenthal, R. S. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.05.040 · Cited by 6
Self-citation
The Role of Computed Tomography and Artificial Intelligence in Evaluating the Comorbidities of Chronic Obstructive Pulmonary Disease: A One-Stop CT Scanning for Lung Cancer Screening
Lin, X., Zhang, Z., Zhou, T., Li, J., Jin, Q., Li, Y., Guan, Y., Xia, Y., Zhou, X., & Fan, L. (2025) · International Journal of COPD · doi:10.2147/copd.s508775 · Cited by 5
Hyperglycaemia and genetic susceptibility in relation to incident degenerative aortic valve stenosis
Chen, C., Huang, Z., Liu, L., Su, B., Feng, Y., & Huang, Y. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf355 · Cited by 5
Exercise and Atrial Fibrillation: Current Evidence, Knowledge Gaps, and Future Directions
Pham, H. N., Abdelnabi, M. H., Ibrahim, R., Sainbayar, E., Truong, H. H., Habib, E., Pathangey, G., Bcharah, G., Singh, A., Arsanjani, R., et al. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm39200 · Cited by 8
Endocrine enigmas: vascular health in females throughout the lifespan
Stone, J. C., Davenport, M. H., Moreau, K. L., Pyke, K. E., Wenner, M. M., Williams, J. S., & MacDonald, M. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00412.2025 · Cited by 5
Ferroptosis: The Pivotal Link in Cardiovascular Diseases Pathogenesis and Therapy
Guo, S., Liu, J., Hua, J., Ding, L., & Chen, Q. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s581227 · Cited by 8
Clinical guidelines on physical activity and exercise therapy for Chinese adults with type 2 diabetes: A clinical practice guideline from the Chinese Society of Endocrinology
Zhang, F., Zhao, J., Zhang, Y., Tian, Z., Li, J., Lü, Q., Wang, W., Hong, T., Shan, Z., Yan, L., et al. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101124 · Cited by 8
Heart Failure Prevention
Butler, J., Khan, M. S., Ferreira, J. P., Girerd, N., Gulati, M., Lala, A., Petrie, M. C., Stockbridge, N., Vaduganathan, M., & Zannad, F. M. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.12.029 · Cited by 5
Statins and survival free of incident frailty among older US veterans
Qazi, S., Charest, B., Pajewski, N. M., Callahan, K. E., Houston, D. K., Espinoza, S. E., Forman, D. E., Alexander, K. P., Djoussé, L., Gaziano, J. M., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag451 · Cited by 5
The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled Trial
Still, C. H., Burant, C. J., Moore, S. M., Einstadter, D., Killion, C. M., Modlin, C. S., Sundararajan, S., Thornton, J. D., Wright, J. T., & Sajatovic, M. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s288753 · Cited by 5
Tecnologias educacionais no cuidado à pacientes com doenças cardiovasculares
de Sant’Anna, R. M., Camacho, A. C. L. F., de Souza, V. M. F., de Menezes, H. F., & Silva, R. P. (2022) · Revista Recien · doi:10.24276/rrecien2022.12.37.163-175 · Cited by 9
Educational level differences in the primary and secondary prevention of stroke
Ma, J., Zeng, F., Han, L., & Guan, Q. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107283 · Cited by 5
Prognostic Value of Estimated Glucose Disposal Rate in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Liu, C., Zhao, Q., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401002 · Cited by 6
“BMI is a currently recognized cardiovascular risk factor [38].”
Background
Reproductive risk factors for cardiovascular disease in women
Quesada, O. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002264 · Cited by 7
Albumin‐To‐Creatinine Ratio Underestimates True 24‐Hour Albuminuria in Obesity: Clinical Relevance for Vascular Risk Stratification
Moriconi, D., Nannipieri, M., Jadoon, M., Solini, A., & Bruno, R. M. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70064 · Cited by 6
Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA Study
Shah, N. S., Agarwal, A., Huffman, M. D., Gupta, D. K., Yancy, C. W., Shah, S. J., Kanaya, A. M., Ning, H., Lloyd‐Jones, D. M., Kandula, N. R., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.05.013 · Cited by 5
Self-citation
Agricultural policy and societal factors influence patients’ ability to follow a healthy diet
Ramesh, G., Belardo, D., Gulati, M., Ostfeld, R. J., & Michos, E. D. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100285 · Cited by 5
Self-citation
A rare cause of chest pain in paediatric age: a teenager with acute myocardial infarction due to spontaneous coronary artery dissection
Cascais, F. C., Pereira, A. R., Almeida, A. R., & Rocha, L. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-246393 · Cited by 5
Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD
Al-Karaghouli, M., Fuentes, S., Davyduke, T., Ma, M., & Abraldeṣ, J. G. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000798 · Cited by 5
Effect of 1PC111, a Fixed-dose Combination of Pitavastatin and Ezetimibe, Versus Pitavastatin or Ezetimibe Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-blind, Multicenter, Phase III Study
Chou, M., McGirr, A., Jong, G., Chao, T., Lee, I., Huang, C., Chen, C.-P., Hsieh, C., Lu, C., & Sheu, W. H. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.08.006 · Cited by 5
Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol
Marschner, S. L., Wing‐Lun, E., Chow, C. K., Maple-Brown, L. J., Graham, S., Nicholls, S. J., Brown, A. D. H., Wood, A. J., Ihdayhid, A. R., Huben, A. V., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062685 · Cited by 5
Meta-analysis of the intervention effects of taekwondo on metabolic syndrome indicators
Han, Z., & Ju, H. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1069424 · Cited by 5
Trends in total cholesterol control among American adults with hypercholesterolemia, 1988–2018
Yang, X., Liu, L., Xi, L., Wu, B., Ku, C., Wang, R., Dai, M., & Ping, Z. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.05.015 · Cited by 5
An Opportunity to Seize From Low Hanging Fruits: Capitalising on Incidentally Reported Coronary Artery Calcification
Teng, L. E., Kennedy, L. P., Lok, S. C., O'Rourke, E., & Premaratne, M. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.07.011 · Cited by 5
Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials
Kelly, M. S., Dacey, A., Siana, A., & Ojeda, J. C. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001508 · Cited by 5
Survival time analysis of the relationship between the residential environment and residents’ health status
Kamata, T., Nakano, J., Fujii, R., Murakami, S., Ikaga, T., & Kawakubo, S. (2024) · Building and Environment · doi:10.1016/j.buildenv.2024.112305 · Cited by 6
Comparison of Traditional and Intensive Cardiac Rehabilitation on Dietary Behavior and Clinical Risk Factor Outcomes
Rasmussen, R. A., Sisson, S. B., Baldwin, J. D., Hord, N. G., Eliot, K. A., Anderson, L., Gowin, M. J., Scott, B. D., & Wortham, D. (2024) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000903 · Cited by 5
Aortic valve microcalcification and cardiovascular risk: an exploratory study using sodium fluoride in high cardiovascular risk patients
Domingues, C. M., Ferreira, M. J., Silva, R., Santos, M. O., Gomes, A. M., Chichorro, N., Lima, J. P., Gonçalves, L. M. M., Castelo-Branco, M. S., & Abrunhosa, A. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01854-0 · Cited by 5
Exercise versus fixed-dose combination therapy for cardiovascular risk factors control and atherosclerotic disease prevention: a network meta-analysis protocol
Pozuelo‐Carrascosa, D. P., Cavero‐Redondo, I., Fernández‐Rodríguez, R., Pascual‐Morena, C., Sequí‐Domínguez, I., & Martínez‐Vizcaíno, V. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036734 · Cited by 5
The Effects of Long-Term Nutrition Counseling According to the Behavioral Modification Stages in Patients with Cardiovascular Disease
Matsuzaki, K., Fukushima, N., Saito, Y., Matsumoto, N., Nagaoka, M., Katsuda, Y., & Miura, S. (2021) · Nutrients · doi:10.3390/nu13020414 · Cited by 5
Walking-induced endothelial dysfunction predicts ischemic cardiovascular events in patients with intermittent claudication
Migliacci, R., Guglielmini, G., Busti, C., Falcinelli, E., Minuz, P., & Gresele, P. (2021) · Vascular Medicine · doi:10.1177/1358863x211001927 · Cited by 5
Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
Wang, M. C., Dolan, B., Freed, B. H., Vega, L., Markoski, N., Wainright, A. E., Kane, B. J., Seegmiller, L. E., Harrington, K. A., Lewis, A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.785109 · Cited by 6
Self-citation
GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice
Coke, L. A., DEEDWANIA, P. C., Hinnen, D., Magwire, M., & Miller, N. H. (2022) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000661 · Cited by 5
Machine learning for predicting 5-year mortality risks: data from the ESSE-RF study in Primorsky Krai
Афанасьевна, Н. В., Brodskaya, T. A., Shakhgeldyan, K. I., Geltser, B. I., Kosterin, V. V., & Priseko, L. G. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-2908 · Cited by 5
Intelligent digitalization of cardiovascular risks
Gromov, Y. Y., Gorbunov, A. V., & Tyutyunnik, V. M. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.22.7794 · Cited by 5
Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach
Grant, J. K., Snow, S. C., Kelsey, M. D., Rymer, J. A., Schaffer, A. E., Patel, M. R., McGarrah, R. W., Pagidipati, N. J., & Shah, N. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01751-z · Cited by 5
Statin Recommendations for Primary Prevention
Návar, A. M., & Peterson, E. D. (2022) · JAMA · doi:10.1001/jama.2022.12982 · Cited by 5
Cardio-oncology: Implications for Clinical Practice for Women
Kassaian, S. E., Gandhi, B., & Barac, A. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01779-1 · Cited by 5
The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation
Fu, J., Wang, T., Li, B., & Zhao, N. (2022) · Disease Markers · doi:10.1155/2022/1111438 · Cited by 5
“amlodipine, and aspirin outperform rosuvastatin and amlodipine alone, which may be attributed to the strong antiplatelet action of aspirin [18].”
Background
Retracted
Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Liu, S., Eckstein, J., Lam, A. P., & Cheema, A. N. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230131120544 · Cited by 7
Combined Cardiac Risk Factors Predict COVID-19 Related Mortality and the Need for Mechanical Ventilation in Coptic Clergy
Henein, M. Y., Bytyçi, I., Nicoll, R., Shenouda, R., Ayad, S. W., Cameli, M., & Vancheri, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102066 · Cited by 5
Shared Decision Making
Feldman, D. I., Dudum, R., & Blumenthal, R. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-75055-8_8 · Cited by 5
Self-citation
Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug
Vilar‐Gómez, E., & Chalasani, N. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.06.032 · Cited by 5
Coronary Artery Calcium Score as a Decision Aid May Be Cost-Effective
Yeboah, J. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.019 · Cited by 5
Self-citation
Icon Arrays for Medical Risk Communication: Do Icon Type and Color Influence Cardiovascular Risk Perception and Recall?
Blase, R., Meis‐Harris, J., Weltermann, B., & Dohle, S. (2024) · Medical Decision Making · doi:10.1177/0272989x241263040 · Cited by 4

Authors: Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
ORCID: Arnett, Donna K.
Blumenthal, Roger S.
Albert, Michelle A.
Goldberger, Zachary D.
Hahn, Ellen J.
Himmelfarb, Cheryl Dennison
Khera, Amit
McEvoy, J. William
Michos, Erin D.
Miedema, Michael D.
Virani, Salim S.
Williams, Kim A.
Yeboah, Joseph
Ziaeian, Boback
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2019-09
Volume: 74
Issue: 10
Pages: 1376-1414
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2019.03.009
PMC: PMC8344373
OpenAlex: W2984766121
Cited by: 1,193
References: 286
Citations by year: 2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
FWCI: 153.80
Type: journal article
Language: en
Update notices: erratum (2020-02-25)
erratum (2019-09-10)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: American Heart Association (17SDG33630113)
National Institutes of Health (KL2TR001882)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks